Not logged in Share Save
Intratumoral preservation of the stem-like malignant cell proportion in glioblastoma, prognostic impact, and its radiomethylomic signatures Matsumoto, Yuji; Singh, Omkar; Garcia, Jose; Abdullaev, Zied; Freeburg, Nelson F.; Yu, Fanyang; Akbari, Hamed; Baik, Kyunglok; Guo, Jun; Shih, Natalie N. C.; Toorens, Erik; Ganguly, Tapan; Ballinger, Dominique; O'Rourke, Donald M.; Mohan, Suyash; Morrissette, Jennifer J. D.; Silverbush, Dana; Aldape, Kenneth; Davatzikos, Christos; Nasrallah, MacLean P. Share Save
Share Save
First-in-human phase I study of EMB-02, a bispecific antibody targeting PD-1 and LAG-3 in patients with advanced solid tumors Day, Daphne; Ganju, Vinod; Chung, Ki; Si, Lu; Mao, Lili; Aghmesheh, Morteza; Hoyer, Robert; Brewin, Kim; Zeng, Shuqi; Zhang, Mingfei; Lu, Qiaoyang; Jiang, Chengjun; Ren, Fang; Zhu, Yonghong; Guo, Jun Share Save
Dynamic Change of PD-L2 on Circulating Plasma Extracellular Vesicles as a Predictor of Treatment Response in Melanoma Patients Receiving Anti-PD-1 Therapy Sun, Linzi; Wei, Xiaoting; Zhao, Qian; Mao, Lili; Bai, Xue; Li, Caili; Gu, Junjie; Kong, Yan; Cui, Chuanliang; Chi, Zhihong; Sheng, Xinan; Lian, Bin; Wang, Xuan; Li, Siming; Yan, Xieqiao; Tang, Bixia; Zhou, Li; Li, Juan; Guo, Jun; Si, Lu; Dai, Jie Share Save
Share Save
SUBTYPING GLIOBLASTOMA FROM JOINT CLUSTERING OF IMAGING AND GENOMIC DATA Guo, Jun; Fathi-Kazerooni, Anahita; Toorens, Erik; Akbari, Hamed; Yu, Fanyang; Matsumoto, Yuji; Sako, Chiharu; Mamourian, Elizabeth; Shinohara, Russell; Koumenis, Constantinos; Verginadis, Ioannis; Bagley, Stephen; Morrissette, Jennifer; Binder, Zev; Brem, Steven; Mohan, Suyash; Lustig, Robert; O'Rourke, Donald; Ganguly, Tapan; Bakas, Spyridon; Aboian, Mariam; Nasrallah, Maclean; Davatzikos, Christos Share Save
Mucin 18-targeted humanized monoclonal antibody immune positron emission tomography imaging and patient-derived tumor xenograft visualization Zhang, Qian; Du, Haizhen; Ma, Xiuli; Liu, Song; Kong, Xiangxing; Hu, Muye; Shi, Jing; Tang, Yanfang; Liu, Shuhui; Meng, Xun; Guo, Qian; Kong, Yan; Guo, Jun; Lian, Bin; Yang, Zhi; Zhu, Hua Share Save
Pharmacokinetics, safety, and efficacy of an alternative dosing regimen of sasanlimab in participants with advanced NSCLC and other malignancies Penkov, Konstantin; Bondarenko, Igor; Saenko, Daria Viktorovna; Kulyaba, Yaroslav; Guo, Jun; Gong, Yi; Yamamoto, Noboru; Hotko, Yevhen Stepanovych; Boyko, Vasyl; Fadeeva, Natalya Vladimirovna; Ursol, Grygorii Mykolaiovych; Ahn, Hee Kyung; Kislov, Nikolay Viktorovich; Shen, Chia-, I; Davis, Craig; Kowalski, Karey; Michelon, Elisabete; Pavlov, Dmitri; Hirohashi, Tomoko; Cho, Byoung Chul Share Save
Mechanisms of recurrence following mRNA-4157 (V940) plus pembrolizumab or pembrolizumab alone in resected melanoma from the mRNA-4157-P201 (KEYNOTE-942) trial Sullivan, R. J.; Lu, M.; Koppolu, S.; Weber, J. S.; Carlino, M. S.; Khattak, M. A.; Ansstas, G.; Taylor, M. H.; Mckean, M.; Long, G. V.; Faries, M. B.; Luke, J. J.; Sehgal, V.; Rao, A.; Mao, H.; Guo, J.; Brown, M.; Meehan, R.; Feldman, I.; Srinivasan, L. Share Save
Phase III study of talazoparib (TALA) plus enzalutamide (ENZA) vs placebo (PBO) plus ENZA as first-line (1L) treatment in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): TALAPRO-2 (TP-2) China cohort Zeng, H.; Ye, D.; Guo, H.; Yang, Y.; Xue, B.; Zhang, X.; Xiao, W.; Jiang, J.; Sun, T.; Chen, W.; Wang, Y.; Wan, B.; He, D.; Zhang, Q.; Luo, H.; Wang, X.; Guo, J.; Ye, H.; Zhao, H.; Zhang, Y. Share Save
Share Save
Chinese quality control indices for standardized diagnosis and treatment of renal cancer (2022 edition) Yao, Lin; Du, Yicong; Dong, Wen; Gao, Xianshu; Guo, Jun; Qiu, Jianxing; Wei, Qiang; Wu, Shikai; Ye, Dingwei; Yu, Wei; Zeng, Hao; Zhang, Qian; Zhang, Yong; Zhang, Zhiling; Zhou, Fangjian; Yang, Wenjing; Wang, Hui; Zhang, Xu; He, Zhisong Share Save
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study Bai, Xue; Shaheen, Ahmed; Grieco, Charlotte; d'Arienzo, Paolo D.; Mina, Florentia; Czapla, Juliane A.; Lawless, Aleigha R.; Bongiovanni, Eleonora; Santaniello, Umberto; Zappi, Helena; Dulak, Dominika; Williamson, Andrew; Lee, Rebecca; Gupta, Avinash; Li, Caili; Si, Lu; Ubaldi, Martina; Yamazaki, Naoya; Ogata, Dai; Johnson, Rebecca; Park, Benjamin C.; Jung, Seungyeon; Madonna, Gabriele; Hochherz, Juliane; Umeda, Yoshiyasu; Nakamura, Yasuhiro; Gebhardt, Christoffer; Festino, Lucia; Capone, Mariaelena; Ascierto, Paolo Antonio; Johnson, Douglas B.; Lo, Serigne N.; Long, Georgina L.; Menzies, Alexander M.; Namikawa, Kenjiro; Mandala, Mario; Guo, Jun; Lorigan, Paul; Najjar, Yana G.; Haydon, Andrew; Quaglino, Pietro; Boland, Genevieve M.; Sullivan, Ryan J.; Furness, Andrew J. S.; Plummer, Ruth; Flaherty, Keith T. Share Save
Share Save
Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA) Wei, Alexander Z.; Chen, Lanyi N.; Orloff, Marlana; Ariyan, Charlotte E.; Asgari, Maryam; Barker, Christopher A.; Buchbinder, Elizabeth; Chandra, Sunandana; Couts, Kasey; Frumovitz, Michael M.; Futreal, Andrew; Gershenwald, Jeffrey E.; Hanna, Ehab Y.; Izar, Benjamin; Leblanc, Amy K.; Leitao, Mario M.; Lipson, Evan J.; Liu, David; Mccarter, Martin; Mcquade, Jennifer L.; Najjar, Yana; Rapisuwon, Suthee; Selig, Sara; Shoushtari, Alexander N.; Yeh, Iwei; Schwartz, Gary K.; Guo, Jun; Patel, Sapna P.; Carvajal, Richard D. Share Save
Second-line pembrolizumab (pembro) in Chinese patients (pts) with advanced melanoma: Long-term follow-up of the phase I KEYNOTE-151 study Si, L.; Zhang, X.; Shu, Y.; Pan, H.; Wu, D.; Liu, J.; Mao, L.; Wang, X.; Wen, X.; Gu, Y.; Zhu, L.; Lan, S.; Cai, X.; Diede, S.; Chen, S. S.; Hu, H.; Guo, J. Share Save
RENOTORCH: Toripalimab combined with axitinib versus sunitinib in first-line treatment of advanced renal-cell carcinoma (RCC) - A randomized, open-label, phase III study Sheng, X.; Ye, M.; Zou, Q.; Chen, P.; He, Z.; Wu, B.; He, D.; He, C.; Xue, X.; Ji, Z.; Chen, H.; Zhang, S.; Liu, Y.; Zhai, W.; Zhang, X.; Fu, C.; Xu, D.; Qiu, M.; Huang, Y.; Guo, J. Share Save
A Cell Surface-Binding Antibody Atlas Nominates a MUC18-Directed Antibody-Drug Conjugate for Targeting Melanoma Shi, Jing; Jiao, Tao; Guo, Qian; Weng, Weining; Ma, Linjie; Zhang, Qing; Wang, Lijun; Zhang, Jianjian; Chen, Caiwei; Huang, Yaling; Wang, Mingqiao; Pan, Rong; Tang, Yanfang; Hu, Wenhao; Meng, Tao; Liu, Shu-Hui; Guo, Jun; Kong, Yan; Meng, Xun Share Save
Phase Ib study of anlotinib in combination with anti-PD-L1 antibody (TQB2450) in patients with advanced acral melanoma Du, Yu; Dai, Jie; Mao, Lili; Wei, Xiaoting; Bai, Xue; Chen, Ling; Lin, Jing; Chi, Zhihong; Cui, Chuanliang; Sheng, Xinan; Lian, Bin; Tang, Bixia; Wang, Xuan; Yan, Xieqiao; Li, Siming; Zhou, Li; Guo, Jun; Chen, Yu; Si, Lu Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
